scholarly journals Efficacy of retreatment with anti-EGFRs in metastatic colorectal cancer is not predictable by clinical factors related to prior lines of therapy: a multi-institutional analysis

2019 ◽  
Vol 30 ◽  
pp. iv118
Author(s):  
D. Rossini ◽  
F. Pagani ◽  
A. Pellino ◽  
E. Dell’Aquila ◽  
N. Liscia ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Institutional Analysis ◽  
Clinical Factors

scholarly journals P-263 The role of biologic targets in metastatic colorectal cancer in non-elderly patients: A single institutional analysis

2020 ◽  
Vol 31 ◽  
pp. S175-S176
Author(s):  
M. Peixoto ◽  
F. Macedo ◽  
M. Sousa ◽  
J. Paulo ◽  
M. Marques ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patients ◽  
Metastatic Colorectal Cancer ◽  
Institutional Analysis

Clinical factors and the role of Wnt regulators in racial disparity of metastatic colorectal cancer survival.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 6551-6551
Author(s):  
Shin Yin Lee ◽  
Umit Tapan ◽  
Moshe Shashar ◽  
Jamaica Siwak ◽  
Qing Zhao ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Racial Disparity ◽  
Cancer Survival ◽  
Clinical Factors ◽  
Colorectal Cancer Survival

scholarly journals OPTIMAL SEQUENCES AND COMBINATION OF CHEMOTHERAPY AND MONOCLONAL ANTIBODIES IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER

2018 ◽  
Vol 8 (2) ◽  
pp. 50-59
Author(s):  
M. Yu. Fedyanin ◽  
S. A. Tjulandin
Keyword(s):  
Colorectal Cancer ◽  
Colon Cancer ◽  
Clinical Trials ◽  
Monoclonal Antibodies ◽  
Targeted Therapy ◽  
Metastatic Colorectal Cancer ◽  
Metastatic Colon Cancer ◽  
Clinical Factors ◽  
Therapy Choice ◽  
The Impact

In this review we analyzed results of studies concerning the choice of first and subsequent lines of therapy in patients with metastatic colon cancer. We discussed data of various combinations of monoclonal antibodies with different chemotherapeutic regimens. Also we discussed modern preclinical and clinical trials concerning strategy of choice of targeted therapy sequence in patients with metastatic disease. We considered the impact of various molecular and clinical factors on the effectiveness of drugs and determined their application for therapy choice for colon cancer.

scholarly journals RAS status in metastatic colorectal cancer: What is the relationship to epidemiological and anatomo-clinical factors?

2018 ◽  
Vol 29 ◽  
pp. v79-v80
Author(s):  
M. Haffadi ◽  
N. Tawfiq ◽  
M. Karkouri ◽  
Z. Bouchbika ◽  
N. Benchakroun ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Clinical Factors ◽  
Ras Status ◽  
The Relationship

Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis

2020 ◽  
Vol 19 (3) ◽  
pp. 191-199.e6
Author(s):  
Daniele Rossini ◽  
Marco Maria Germani ◽  
Filippo Pagani ◽  
Antonio Pellino ◽  
Emanuela Dell’Aquila ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Institutional Analysis ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document